Lisaftoclax T10483
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Bcl-2/Bcl-xl inhibitor 1 is a dual Bcl-2 and Bcl-xl inhibitor (IC50s: 2 nM and 5.9 nM for Bcl-2 and Bcl-xl) with anti-tumor activity. It is extracted from patent WO2018027097A1.
CAS nr:
2180923-05-9
Purity:
98%
Molecular Weight:
882,42
SMILES:
O=C(NS(=O)(C1=CC=C(NC[C@@H]2OCCOC2)C([N+]([O-])=O)=C1)=O)C3=CC=C(N4CCN(CC(CC5)=C(C6=CC=C(Cl)C=C6)CC75CCC7)CC4)C=C3OC8=CN=C(NC=C9)C9=C8
Formula:
C45H48ClN7O8S
Pathway:
Apoptosis
Target:
BCL
